With demand for healthcare services expected to rise considerably over the next couple of decades as populations age and better treatments are developed, I think it is well worth investors having exposure to the healthcare sector.
While there are many quality shares to choose from in the sector, three of my favourites are listed below:
Cochlear Limited (ASX: COH)
I think this leading hearing solutions company is one of the best buy and hold investment options on the local market. This is because I feel there are few shares on the ASX which stand to benefit as greatly as Cochlear from the ageing populations tailwind. As people age their hearing will invariably fade, making hearing products like those Cochlear develops and sells invaluable. This could allow Cochlear to continue its above-average earnings growth long into the future.
CSL Limited (ASX: CSL)
If you only buy one healthcare share I would make it CSL Limited. In my opinion the biotherapeutics company is one of Australia’s highest quality companies and would be a great addition to most portfolios. I’m not alone in thinking this way either. A recent note out of Goldman Sachs reveals that its analysts have initiated coverage on CSL with a buy rating and $231.00 price target.
Pro Medicus Limited (ASX: PME)
This healthcare technology company may not be as well-known as CSL and Cochlear, but it could be one day. Pro Medicus has caught my eye due to its increasingly popular Visage 7 and Visage RIS platforms. While both platforms are impressive, the Visage 7 software is the standout for me. It provides radiologists and referring physicians with fast server-side rendered images streamed via an intelligent thin-client viewer. This allows users to have a customised protocol-driven workflow to natively view multi-dimensional imagery and a patient’s complete imaging history.
It's not just Cochlear, CSL, and Pro Medicus that are in the buy zone, these hot stocks are top buys right now.
Renowned investor Scott Phillips just released a brand-new report detailing his 4 favourite stocks to buy right now.
And I don’t know about you, but I always pay attention when some of the best investors in the world give me a stock tip.
This is your chance to get in at the very beginning of what could prove to be very special investments.
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended PRO Medicus Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.